1. Overview of current systemic management of EGFR-mutant NSCLC
2. National Comprehensive Cancer Network. Non-small cell lung cancer (version 6.2021). Available from: https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendations/GetFileFromFileManagerGuid?FileManagerGuidId=b53b73e4-9354-4bd0-995b-f1089574d01b. Accessed January 10, 2022.
3. Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers
4. Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer
5. Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC